Genzyme Leukemia Drug Given FDA Approval
88298
Genzyme Corp. on Wednesday said the Food and Drug Administration gave marketing approval for Clolar, its agent aimed at treating children with leukemia who have failed prior therapies.
108565
Danish biotech Genmab A/S on Tuesday signed a deal worth up to $2.1 billion with pharmaceutical company GlaxoSmithKline PLC for the global commercialization of a leukemia treatment.
752431
A panel of medical experts on Wednesday recommended approval for Ilex Oncology Inc.&#39;s (ILXO.O: Quote, Profile, Research) new drug Clolar for use against one type of leukemia but not against another.
560148
The Food and Drug Administration approved Clolar, Genzyme Corp.&#39;s new drug for patients under 21 with acute lymphocytic leukemia.
554059
A second-line drug to treat a life-threatening form of leukemia has won federal approval, the Food and Drug Administration said Monday.
340456
A once-a-month drug for treating  multiple sclerosis that appears to cut relapses of the  autoimmune disorder was approved on Tuesday by the U.S. Food  and Drug Administration.
770040
An experimental antibody drug being developed by Danish biotech company Genmab and Britain's GlaxoSmithKline Plc confirmed its promise as a rheumatoid arthritis treatment on Friday.
501444
The Food and Drug Administration has approved a new drug for multiple sclerosis that in clinical trials got better results than existing drugs in protecting against relapses.
232342
Genzyme (GENZ :Nasdaq - news - research) shares rose early Wednesday after US regulators approved its leukemia drug for children. The Food and Drug Administration Tuesday approved the drug Clolar, an intravenous
594161
Genzyme announces positive study results with a recently acquired drug.
756718
The Food and Drug Administration has approved a pediatric leukemia drug developed by Southern Research Institute of Birmingham. It is the first new treatment in a decade for children who have been stricken with the life-threatening disease.
96500
Genzyme Corp. , the biotech firm expanding into the market for cancer treatments, said fourth-quarter revenue rose 23 percent to $591 million on higher sales of its Cerezyme treatment for Gaucher disease. Revenue increased from $481 million a year earlier, the Cambridge company said in an e-mailed statement. Profit for the full year 2004, excluding some items, rose to $1.75 ...
301333
NEW YORK  - Genzyme Corp. announced  Wednesday that its drug Clolar has been approved by the U.S.  Food and Drug Administration (FDA) for the treatment of  children with difficult or relapsed acute lymphoblastic  leukemia (ALL).
127464
The Food and Drug Administration has approved a new form of the widely used cancer drug Taxol that is easier to administer and avoids some side effects.
143377
The Food and Drug Administration (FDA) today cleared for marketing the first laboratory test system that will allow physicians to consider unique genetic information from patients in selecting medications and doses of medications for a wide variety of
113986
The Food and Drug Administration strongly endorsed Biogen Idec Inc.&#39;s new multiple sclerosis treatment, putting the Cambridge firm in position to expand the market for MS drugs and win greater market share.
199535
Wyeth Pharmaceuticals said on Monday it  received U.S. regulatory approval for a kit designed to help  patients with the blood disorder hemophilia get regular  treatments more quickly and safely.